Missing/wrong data?
Log in to edit
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
scientific article published in September 2006
Author/s
author: Paul Emery, Gerd-Rüdiger Burmester, Maxime Dougados, Stanley B Cohen
Work details
Publication date
September 1, 2006
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.